NAFDAC DG links Nigeria’s counterfeit medicine crisis to regulatory gaps

Nigeria’s NAFDAC Director-General has attributed the country’s counterfeit medicine crisis to gaps in the regulatory system. The assessment indicates that weaknesses in oversight or enforcement may be enabling fake medicines to circulate, highlighting regulatory shortcomings as a central factor in the public health challenge.